United Therapeutics Corporation (UTHR) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript
United Therapeutics Corp UTHR
$563.98
▲ +0.01%
(+$0.05)
Open
$560.47
Prev Close
$563.93
Day Range
$555.25 – $567.32
52W Range
$272.12 – $609.35
Market Cap
$24.06B
P/E (TTM)
18.69
Beta
0.59
EPS (TTM)
$27.09
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 1999-06-17 |
| Shares Out. | 42,450,000 |
| Website | unither.com/ ↗ |
| Phone | 13016089292 |
United Therapeutics Corp is a publicly traded company under the ticker symbol UTHR on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
22 analysts (2026-05-01)
📰 Latest News for UTHR
Tectonic Therapeutics: Currently In A Catalyst Vacuum
United Therapeutics Corporation Announces TETON-1 Study of Tyvaso Published in The New England Journal of Medicine and Presented at ATS 2026
United Therapeutics Says New England Journal Of Medicine Publishes Full Results Of TETON-1 Study And Combined Analyses Of TETON-1, TETON-2 Studies, Evaluating Use Of Nebulized Tyvaso For Treatment Of IPF
United Therapeutics Corporation Announces FDA Clearance to Proceed with UHeart Xenotransplantation Clinical Trial
MannKind Corp. (MNKD) Reports Q1 2026 Total Revenues of $90.2M
Baidu, Brady And 3 Stocks To Watch Heading Into Monday
United Therapeutics Corporation Announces ADVANCE OUTCOMES Study of Ralinepag Presented at ATS 2026